ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q3 2024

GOTHENBURG, Sweden, Oct. 3, 2024 /PRNewswire/ -- Zinzino group revenue increased 22% in Q3, compared with the previous year.

The revenue in September for Zinzino's sales markets increased by 20 % and amounted to SEK 177.8 (148.3) million. Faun Pharma's external sales decreased and amounted to SEK 5.8 (9.9) million. Overall, the Group increased revenues by 16% to SEK 183.6 (158.2) million compared with the previous year.

Sales in Zinzino's sales markets increased by 22% in the third quarter of 2024 compared with the same period last year and amounted to SEK 503.9 (413.8) million. Total revenues in the Group increased by 22 % in the third quarter and amounted to SEK 531.9 (436.9) million.

Accumulated revenue for January – September 2024 increased by 21% to SEK 1493.5 (1238.5) million.

Revenues were distributed as follows:

Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com 

Pictures for publication free of charge: marketing@zinzino.com

Certified Adviser: Carnegie Investment Bank AB (publ)

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/zinzino/r/zinzino-ab--publ--preliminary-sales-report-q3-2024,c4046818

The following files are available for download: